<bill session="108" type="s" number="15" updated="2023-01-15T22:48:22Z">
  <state datetime="2004-07-21">ENACTED:SIGNED</state>
  <status>
    <unknown datetime="2004-07-21"/>
  </status>
  <introduced datetime="2003-03-11"/>
  <titles>
    <title type="display">Project BioShield Act of 2004</title>
    <title type="official" as="amended by senate">A bill to amend the Public Health Service Act to provide protections and countermeasures against chemical, radiological, or nuclear agents that may be used in a terrorist attack against the United States by giving the National Institutes of Health contracting flexibility, infrastructure improvements, and expediting the scientific peer review process, and streamlining the Food and Drug Administration approval process of countermeasures.</title>
    <title type="official" as="introduced">A bill to amend the Public Health Service Act to provide for the payment of compensation for certain individuals with injuries resulting from the administration of smallpox countermeasures, to provide protections and countermeasures against chemical, radiological, or nuclear agents that may be used in a terrorist attack against the United States, and to improve immunization rates by increasing the distribution of vaccines and improving and clarifying the vaccine injury compensation program.</title>
    <title type="short" as="introduced">Biodefense Improvement and Treatment for America Act</title>
    <title type="short" as="introduced" partial="1">Improved Vaccine Affordability and Availability Act</title>
    <title type="short" as="introduced" partial="1">Project BioShield Act of 2003</title>
    <title type="short" as="introduced" partial="1">Smallpox Emergency Personnel Protection Act of 2003</title>
    <title type="short" as="enacted">Project BioShield Act of 2004</title>
    <title type="short" as="passed senate">Project Bioshield Act of 2004</title>
    <title type="short" as="passed house">Project BioShield Act of 2004</title>
    <title type="short" as="reported to senate">Project BioShield Act of 2003</title>
    <title type="popular">Vaccine Compensation bill</title>
  </titles>
  <sponsor bioguide_id="G000445"/>
  <cosponsors>
    <cosponsor bioguide_id="A000360" joined="2003-03-11"/>
    <cosponsor bioguide_id="B000611" joined="2003-03-12"/>
    <cosponsor bioguide_id="E000285" joined="2003-03-11"/>
    <cosponsor bioguide_id="F000442" joined="2003-04-09"/>
    <cosponsor bioguide_id="F000439" joined="2003-03-11"/>
    <cosponsor bioguide_id="G000359" joined="2003-03-11"/>
    <cosponsor bioguide_id="I000024" joined="2003-03-19"/>
    <cosponsor bioguide_id="R000307" joined="2003-03-11"/>
    <cosponsor bioguide_id="S001141" joined="2003-03-11"/>
    <cosponsor bioguide_id="S000888" joined="2003-03-25"/>
    <cosponsor bioguide_id="W000154" joined="2003-03-11"/>
  </cosponsors>
  <actions>
    <action datetime="2003-03-11">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2003-03-11" state="REFERRED">
      <text>Read twice and referred to the Committee on Health, Education, Labor, and Pensions.</text>
    </action>
    <action datetime="2003-03-19" state="REPORTED">
      <text>Committee on Health, Education, Labor, and Pensions. Ordered to be reported with an amendment in the nature of a substitute favorably.</text>
    </action>
    <action datetime="2003-03-25">
      <text>Committee on Health, Education, Labor, and Pensions. Reported by Senator Gregg with an amendment in the nature of a substitute. Without written report.</text>
    </action>
    <calendar datetime="2003-03-25" calendar="Senate Legislative" under="General Orders" number="53">
      <text>Placed on Senate Legislative Calendar under General Orders. Calendar No. 53.</text>
    </calendar>
    <action datetime="2003-03-27">
      <text>Star Print ordered on the reported bill.</text>
    </action>
    <action datetime="2004-05-19">
      <text>Measure laid before Senate by unanimous consent.</text>
      <reference ref="CR S5744-5767" label="consideration"/>
      <reference ref="CR S5744-5760" label="text of measure as reported in Senate"/>
    </action>
    <action datetime="2004-05-19">
      <text>The committee substitute as amended agreed to by Unanimous Consent.</text>
    </action>
    <vote how="roll" type="vote" roll="99" datetime="2004-05-19" where="s" result="pass" state="PASS_OVER:SENATE">
      <text>Passed Senate with an amendment and an amendment to the Title by Yea-Nay Vote. 99 - 0. Record Vote Number: 99.</text>
    </vote>
    <action datetime="2004-05-20T10:04:24-04:00">
      <text>Received in the House.</text>
    </action>
    <action datetime="2004-05-20">
      <text>Message on Senate action sent to the House.</text>
    </action>
    <action datetime="2004-05-20T18:42:20-04:00">
      <text>Held at the desk.</text>
    </action>
    <action datetime="2004-07-14T17:19:41-04:00">
      <text>Consideration initiated by previous order of the House.</text>
    </action>
    <action datetime="2004-07-14T17:19:57-04:00">
      <text>Considered by a previous order of the House.</text>
      <reference ref="CR H5721-5741" label="consideration"/>
    </action>
    <action datetime="2004-07-14T17:20:06-04:00">
      <text>DEBATE - Pursuant to a previous order, the House proceeded with ninety minutes of debate on S. 15.</text>
    </action>
    <action datetime="2004-07-14T18:31:49-04:00">
      <text>The previous question was ordered pursuant to a previous  order of the House.</text>
      <reference ref="CR H5740" label="consideration"/>
    </action>
    <vote how="roll" type="vote2" roll="376" datetime="2004-07-14T18:58:04-04:00" where="h" result="pass" state="PASSED:BILL">
      <text>On passage Passed by the Yeas and Nays: 414 - 2 (Roll no. 376).</text>
      <reference ref="CR H5721-5729" label="text"/>
    </vote>
    <action datetime="2004-07-14T18:58:08-04:00">
      <text>Motion to reconsider laid on the table Agreed to without objection.</text>
    </action>
    <topresident datetime="2004-07-16">
      <text>Presented to President.</text>
    </topresident>
    <signed datetime="2004-07-21" state="ENACTED:SIGNED">
      <text>Signed by President.</text>
    </signed>
    <enacted number="108-276" type="public" datetime="2004-07-21">
      <text>Became Public Law No: 108-276.</text>
    </enacted>
  </actions>
  <committees>
    <committee code="SSHR" name="Senate Health, Education, Labor, and Pensions" subcommittee="" activity="Reporting, Markup, Referral"/>
  </committees>
  <relatedbills>
    <bill session="108" type="h" number="2122" relation="companion"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
    <term name="AIDS (Disease)"/>
    <term name="Access to health care"/>
    <term name="Administrative procedure"/>
    <term name="Antibiotics"/>
    <term name="Antitrust law"/>
    <term name="Appropriations"/>
    <term name="Armed Forces and National Security"/>
    <term name="Biological warfare"/>
    <term name="Black colleges"/>
    <term name="Brain diseases"/>
    <term name="Chemical warfare"/>
    <term name="Child health"/>
    <term name="Civil actions and liability"/>
    <term name="Clinical trials"/>
    <term name="Clinics"/>
    <term name="Colleges"/>
    <term name="Commerce"/>
    <term name="Communication in medicine"/>
    <term name="Compensation (Law)"/>
    <term name="Congress"/>
    <term name="Congressional investigations"/>
    <term name="Congressional reporting requirements"/>
    <term name="Counseling"/>
    <term name="Crime and Law Enforcement"/>
    <term name="Damages"/>
    <term name="Department of Health and Human Services"/>
    <term name="Department of Homeland Security"/>
    <term name="Drug approvals"/>
    <term name="Drug industry"/>
    <term name="Drug resistance in microorganisms"/>
    <term name="EBB Terrorism"/>
    <term name="Earnings"/>
    <term name="Economics and Public Finance"/>
    <term name="Education"/>
    <term name="Emergency Management"/>
    <term name="Emergency medicine"/>
    <term name="Environmental Protection"/>
    <term name="Export controls"/>
    <term name="Families"/>
    <term name="Federal advisory bodies"/>
    <term name="Federal employees"/>
    <term name="Federal officials"/>
    <term name="Federal preemption"/>
    <term name="Fines (Penalties)"/>
    <term name="Fire fighters"/>
    <term name="Foreign Trade and International Finance"/>
    <term name="Government Operations and Politics"/>
    <term name="Government liability"/>
    <term name="Government procurement"/>
    <term name="Government publicity"/>
    <term name="Government trust funds"/>
    <term name="Governmental investigations"/>
    <term name="Guardian and ward"/>
    <term name="Health counseling"/>
    <term name="Health education"/>
    <term name="Health warnings"/>
    <term name="Hepatitis"/>
    <term name="Higher education"/>
    <term name="Human immunodeficiency viruses"/>
    <term name="Influenza"/>
    <term name="Informed consent (Medical law)"/>
    <term name="Injunctions"/>
    <term name="International Affairs"/>
    <term name="Jurisdiction"/>
    <term name="Labor and Employment"/>
    <term name="Laboratories"/>
    <term name="Law"/>
    <term name="Law enforcement officers"/>
    <term name="Legal fees"/>
    <term name="Liability (Law)"/>
    <term name="Licenses"/>
    <term name="Limitation of actions"/>
    <term name="Medical laboratories"/>
    <term name="Medical personnel"/>
    <term name="Medical research"/>
    <term name="Medical screening"/>
    <term name="Medical statistics"/>
    <term name="Medical supplies"/>
    <term name="Military medicine"/>
    <term name="Military personnel"/>
    <term name="Minorities"/>
    <term name="Minority education"/>
    <term name="National Institutes of Health (NIH)"/>
    <term name="Nuclear terrorism"/>
    <term name="Pharmaceutical research"/>
    <term name="Police"/>
    <term name="Preventive medicine"/>
    <term name="Prisons"/>
    <term name="Public health administration"/>
    <term name="Radiation"/>
    <term name="Radiation victims"/>
    <term name="Radioactivity"/>
    <term name="Recruiting of employees"/>
    <term name="Research and development"/>
    <term name="Research centers"/>
    <term name="Research grants"/>
    <term name="Science, Technology, Communications"/>
    <term name="Scientists in government"/>
    <term name="Sexually transmitted diseases"/>
    <term name="Smallpox"/>
    <term name="Social Welfare"/>
    <term name="State laws"/>
    <term name="Survivors' benefits"/>
    <term name="Terrorism"/>
    <term name="Transportation and Public Works"/>
    <term name="Travel"/>
    <term name="Travel agents"/>
    <term name="Vaccination"/>
    <term name="Vaccines"/>
    <term name="Workers' compensation"/>
  </subjects>
  <amendments>
    <amendment number="s3180"/>
    <amendment number="s3178"/>
  </amendments>
  <summary date="2006-11-28T17:35:40Z" status="Reported to Senate with amendment(s)">Project BioShield Act of 2003 - (Sec. 2) Amends the Public Health Service Act to declare that the National Institute of Allergy and Infectious Diseases shall be the lead institute for performing, administering, or supporting biomedical countermeasure research and development. Defines a biomedical countermeasure as a drug, biological product, or device that is used to treat, identify, or prevent harm from: (1) a biological, chemical, radiological, or nuclear agent that may cause a public health emergency affecting national security; or (2) a potentially harmful condition arising from the administering of a drug, biological product, or device in response to such an agent.Grants the Secretary of Health and Human Services (the Secretary): (1) expedited procurement authority regarding property or services for use in performing, administering, or supporting biomedical countermeasure research or development; (2) the authority to expedite peer review under this section as deemed necessary to obtain a likely contribution to the field of biomedical countermeasure research; and (3) the authority to secure the personal services of experts or consultants with relevant qualifications for the purpose of performing, administering, and supporting biomedical countermeasure research and development.Classifies a person carrying out a contract under this section, and an officer, employee, or governing board member of such person, to be deemed an employee of the Department of Health and Human Services for purposes of claims under specified law for money damages for personal injury, including death.(Sec. 3) Directs the Secretary of Homeland Security, on an ongoing basis, to assess threats of use of chemical, biological, radiological, and nuclear agents and determine which threats pose a material risk of use against the United States population. Requires the Secretary of Homeland Security to assess the public health consequences of such potential uses and to determine the agents for which countermeasures are necessary to protect the public health. Authorizes the Secretary and the Secretary of Homeland Security to jointly submit to the President for approval proposals to call for needed countermeasures. Directs the Secretaries to inform persons who may respond to each approved call. Requires the Secretary, in consultation with the Secretary of Homeland Security, to determine countermeasures appropriate for procurement and inclusion in the stockpile under the Public Health and Bioterrorism Preparedness and Response Act of 2002. Directs the Secretary to annually determine and report to the President whether there is a significant commercial market for products identified as appropriate for procurement other than as biomedical countermeasures. Directs the Secretary to procure countermeasures that have been approved by the President.Authorizes appropriations.(Sec. 4) Amends the Federal Food, Drug, and Cosmetic Act to allow the Secretary to declare a national emergency under specified conditions and authorize the release of a drug or device intended solely for use in an emergency. Directs the Secretary to impose requirements on the authorization to ensure that health care professionals administering the product and persons to whom the product is administered are fully informed about the benefits and risks involved and other alternatives. Requires the Secretary to periodically review an authorization under this Act, and authorizes the Secretary to revoke such an authorization if circumstances so warrant. Imposes civil monetary penalties for violation of this section. Allows the President, under specified circumstances in cases involving the Armed Forces, to waive the requirement that individuals be allowed to refuse administration of a countermeasure. Applies record keeping requirements under the Act to products authorized under this Act for use in emergencies.(Sec. 5) Amends Public Health Service Act provisions concerning the administration of smallpox countermeasures by health professionals, including to modify the definitions of covered countermeasure, covered person, and qualified person.(Sec. 6) Directs the Comptroller General to report to Congress regarding this Act.</summary>
</bill>
